PURPOSE:Auto-titrating continuous positive airway pressure (APAP) is an effective treatment for obstructive sleep apnea/hypopnea syndrome (OSAHS). We investigated whether a single group education session on APAP therapy is effective in promoting adherence among patients with OSAHS. METHODS: This prospective, randomized, controlled, parallel group study included patients newly diagnosed with OSAHS who met criteria for APAP therapy. Patients were randomized into a study group and a control group. All patients in the study group were assigned to a single group education session, 1 month after beginning APAP therapy. RESULTS: We evaluated 146 patients. The median percentage of APAP usage days was 88.3 %, with a median duration per day of use of 6.02 h; 59 % were classified as adherent. Overall, no significant difference in adherence was seen between the study and the control groups. Analyzing patient subgroups, the group session significantly improved APAP adherence among males and patients who were younger (<65 years old), obese (BMI ≥ 35 kg/m(2)), non-sleepy (Epworth sleepiness scale ≤ 11), smokers or past smokers, had hypertension or nocturia and those with non-severe OSAHS. CONCLUSION: To maximize the impact of group education sessions and, by that, saving resources, it may be important to select patients likely to benefit from these sessions.
RCT Entities:
PURPOSE: Auto-titrating continuous positive airway pressure (APAP) is an effective treatment for obstructive sleep apnea/hypopnea syndrome (OSAHS). We investigated whether a single group education session on APAP therapy is effective in promoting adherence among patients with OSAHS. METHODS: This prospective, randomized, controlled, parallel group study included patients newly diagnosed with OSAHS who met criteria for APAP therapy. Patients were randomized into a study group and a control group. All patients in the study group were assigned to a single group education session, 1 month after beginning APAP therapy. RESULTS: We evaluated 146 patients. The median percentage of APAP usage days was 88.3 %, with a median duration per day of use of 6.02 h; 59 % were classified as adherent. Overall, no significant difference in adherence was seen between the study and the control groups. Analyzing patient subgroups, the group session significantly improved APAP adherence among males and patients who were younger (<65 years old), obese (BMI ≥ 35 kg/m(2)), non-sleepy (Epworth sleepiness scale ≤ 11), smokers or past smokers, had hypertension or nocturia and those with non-severe OSAHS. CONCLUSION: To maximize the impact of group education sessions and, by that, saving resources, it may be important to select patients likely to benefit from these sessions.
Authors: Carol E Smith; Emily R Dauz; Faye Clements; Florence N Puno; David Cook; Gary Doolittle; William Leeds Journal: Telemed J E Health Date: 2006-06 Impact factor: 3.536
Authors: Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack Journal: Sleep Date: 2007-06 Impact factor: 5.849
Authors: Helder Novais Bastos; Ana Verónica Cardoso; Ana Sofia Castro; Rita Gomes; Tiago Pinto; Anabela Marinho; Maria Sucena; João Almeida; Marta Drummond; João Carlos Winck Journal: Sleep Breath Date: 2015-06-12 Impact factor: 2.816
Authors: Anuradhani Kasturiratne; Khadija I Khawaja; Sajjad Ahmad; Samreen Siddiqui; Khurram Shahzad; Lathika K Athauda; Ranil Jayawardena; Sara Mahmood; Mirthe Muilwijk; Tayyaba Batool; Saira Burney; Matthew Glover; Saranya Palaniswamy; Vodathi Bamunuarachchi; Manju Panda; Suren Madawanarachchi; Baldeesh Rai; Iqra Sattar; Wnurinham Silva; Swati Waghdhare; Marjo-Riitta Jarvelin; Ravindra P Rannan-Eliya; Heather M Gage; Irene G M van Valkengoed; Jonathan Valabhji; Gary S Frost; Marie Loh; Ananda R Wickremasinghe; Jaspal S Kooner; Prasad Katulanda; Sujeet Jha; John C Chambers Journal: Trials Date: 2021-12-18 Impact factor: 2.279